Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency

NCT ID: NCT02293759

Last Updated: 2016-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-10-31

Study Completion Date

2016-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile.

Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Elderly patients with bleeding tendency either secondary;

1. Strict antiplatelet intake
2. Strict anticoagulant intake
3. uncorrected natural bleeding tendency e.g; patients with liver cell failure are at higher risk of perioperative bleeding when subjected to prostate surgery.

Laser prostate surery was introduced to overcome this difficulty. However, till now there is no head to head comparision of different types of laser procedures in treating this subset of patients In the current study patients presented for BPH surgery in a tertiarry referral prostate unit will be assessed for bleeding tendency and will be treated either by Holmium laser enucleatiuon of the prostate or Greenlight laser vaporization of the prostate Single surgeon will perform all cases

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Prostatic Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HoLEP

Holmium laser enucleation of the prostate

Group Type ACTIVE_COMPARATOR

HoLEP

Intervention Type PROCEDURE

Holmium laser enucleation of the prsotate

Greenlight laser PVP

Phtoselective vaporization of the prostate

Group Type ACTIVE_COMPARATOR

Greenlight laser PVP

Intervention Type PROCEDURE

Greenlight laser (532nm) Photoslective vaporization of the prostate

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HoLEP

Holmium laser enucleation of the prsotate

Intervention Type PROCEDURE

Greenlight laser PVP

Greenlight laser (532nm) Photoslective vaporization of the prostate

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* BPH patients candidate for transurethral prostate surgery after failure of medical treatment
* Perioperative uncorrected Blleding tendency

1. patients with naturally induced uncorrectable bleeding tendency;

1. platelet count less than 100000/mm3
2. INR more than 1.5
2. Patients on oral antiplatlet that deemed unsafe to stop prior to surgery as per intenist
3. Patients on oral anticoagulant that deemed unsafe to stop prior to surgery as per intenist

Exclusion Criteria

* Correctable bleeding tendency
Minimum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mansoura University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Elshal

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed m Elshal, MD

Role: PRINCIPAL_INVESTIGATOR

Mansoura University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Urology and Nephrology Center

Al Mansurah, Aldakahlia, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed m Elshal, MD

Role: CONTACT

+20502262222 ext. 1428

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed M Elshal, MD

Role: primary

00201001855490

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Mans-2014-04

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HoLEP Vs BPEP for Large Prostatic Adenoma
NCT04275076 COMPLETED PHASE3